These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 6172913)

  • 21. [Palliative radiophosphorus therapy for analgesia in bone metastases].
    Grossmann J; Deckart H; Weiss M
    Radiobiol Radiother (Berl); 1988; 29(6):735-6. PubMed ID: 2473483
    [No Abstract]   [Full Text] [Related]  

  • 22. Treating symptomatic osseous metastases from prostate cancer.
    Soffen EM; Greenberg AS; Baumann JC
    N J Med; 1997 Nov; 94(11):33-7. PubMed ID: 9385818
    [No Abstract]   [Full Text] [Related]  

  • 23. [Strontium-89 for bone metastases from prostate cancer: an update].
    Zhao WW; Xie P; Deng HF
    Zhonghua Nan Ke Xue; 2010 Mar; 16(3):269-72. PubMed ID: 20369560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy.
    Malmberg I; Persson U; Ask A; Tennvall J; Abrahamsson PA
    Urology; 1997 Nov; 50(5):747-53. PubMed ID: 9372886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [2 years of experience with 89Sr therapy of multiple bone metastases (author's transl)].
    Correns HJ; Mitterlechner E; Buchali K; Schnorr D; Seidel C; Mebel M
    Radiobiol Radiother (Berl); 1979 Jun; 20(3):360-2. PubMed ID: 515396
    [No Abstract]   [Full Text] [Related]  

  • 26. [Internal strontium-89 radiotherapy for malignant bony metastasis].
    Lou C; Zhang D; Yu L
    Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):507-9. PubMed ID: 11859724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate.
    Cheung A; Driedger AA
    Radiology; 1980 Jan; 134(1):209-12. PubMed ID: 6153129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with strontium-89 in prostatic and breast cancer patients.
    Robinson RG; Preston DF; Baxter KG; Dusing RW; Spicer JA
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):44-8. PubMed ID: 8503027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The palliation of osseous metastasis with 32P or 89Sr compared with external beam and hemibody irradiation: a historical perspective.
    Montebello JF; Hartson-Eaton M
    Cancer Invest; 1989; 7(2):139-60. PubMed ID: 2477119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 89Strontium in the management of painful sceletal metastases.
    Kälkner KM; Westlin JE; Strang P
    Anticancer Res; 2000; 20(2B):1109-14. PubMed ID: 10810404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma.
    Baczyk M; Czepczyński R; Milecki P; Pisarek M; Oleksa R; Sowiński J
    Nucl Med Commun; 2007 Apr; 28(4):245-50. PubMed ID: 17325585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [89-Strontium for painful osteoblastic metastases].
    Golan H; Ratz D
    Harefuah; 1995 May; 128(10):650-4. PubMed ID: 7541384
    [No Abstract]   [Full Text] [Related]  

  • 33. Bone pain palliation with strontium-89 in cancer patients with bone metastases.
    Giammarile F; Mognetti T; Resche I
    Q J Nucl Med; 2001 Mar; 45(1):78-83. PubMed ID: 11456379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Strontium-89: a desirable therapeutic for bone metastases of prostate cancer].
    Ma YB; Yan WL; Dai JC; Xu F; Yuan Q; Shi HH
    Zhonghua Nan Ke Xue; 2008 Sep; 14(9):819-22. PubMed ID: 18998467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disseminated intravascular coagulation in a patient with metastatic prostate cancer: fatal outcome following strontium-89 therapy.
    Leong C; McKenzie MR; Coupland DB; Gascoyne RD
    J Nucl Med; 1994 Oct; 35(10):1662-4. PubMed ID: 7931669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radionuclide-targeted therapy for the management of metastatic bone pain.
    Ackery D; Yardley J
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):27-31. PubMed ID: 7684862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strontium-89 therapy for painful osseous metastatic prostate and breast cancer.
    Hansen DV; Holmes ER; Catton G; Thorne DA; Chadwick DH; Schmutz DA
    Am Fam Physician; 1993 Jun; 47(8):1795-800. PubMed ID: 7684554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiopharmaceuticals in clinical trials.
    Holmes RA
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):22-6. PubMed ID: 7684861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum PICP as a bone formation marker in 89Sr and external beam radiotherapy of prostatic bony metastases.
    Papatheofanis FJ
    Br J Radiol; 1997 Jun; 70(834):594-8. PubMed ID: 9227252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autopsy of a cadaver containing strontium-89-chloride.
    Schraml FV; Parr LF; Ghurani S; Silverman ED
    J Nucl Med; 1997 Mar; 38(3):380-2. PubMed ID: 9074523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.